1,191
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Consumers' Perceptions of Edible Marijuana Products for Recreational Use: Likes, Dislikes, and Reasons for Use

, , &

References

  • Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., … Wiley, J. L. (2016). Tasty THC: Promises and challenges of cannabis edibles. (Report No. OP-0035-1611). Research Triangle Park, NC: RTI Press. Retrieved from https://www.rti.org/publication/tasty-thc-promises-and-challenges-cannabis-edibles
  • Bosker, W. M., Kuypers, K. P., Theunissen, E. L., Surinx, A., Blankespoor, R. J., Skopp, G., … Ramaekers, J. G. (2012). Medicinal Delta(9)—Tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests. Addiction, 107, 1837–1844.
  • Brohl, B., Kammerzell, R., & Koski, W. L. (2015). Colorado marijuana enforcement division: Annual update. Denver, CO: Colorado Department of Revenue.
  • Code of Colorado Regulations. 1 CCR 212-2 Retail Marijuana Rules. (2016).
  • Duff, C., Asbridge, M., Brochu, S., Cousineau, M.-M., Hathaway, A. D., Marsh, D., & Erickson, P. G. (2012). A Canadian perspective on cannabis normalization among adults. Addiction Research & Theory, 20(4), 271–283.
  • Friese, B., Slater, M. D., Annechino, R., & Battle, R. S. (2016). Teen use of marijuana edibles: A focus group study of an emerging issue. Journal of Primary Prevention, 37(3), 303–309. doi:10.1007/s10935-016-0432-9
  • Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327–360. doi:10.2165/00003088-200342040-00003
  • Hancock-Allen, J. B., Barker, L., VanDyke, M., & Holmes, D. B. (2015). Notes from the Field: Death following ingestion of an edible marijuana product—Colorado, March 2014. MMWR Morbidity and Mortality Weekly Report, 64(28), 771–772.
  • Hathaway, A. D. (2004). Cannabis users' informal rules for managing stigma and risk. Deviant Behavior, 25(6), 559–577.
  • Hathaway, A. D., Comeau, N. C., & Erickson, P. G. (2011). Cannabis normalization and stigma: Contemporary practices of moral regulation. Criminology and Criminal Justice, 11(5), 451–469. doi:10.1177/1748895811415345
  • Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804. doi:10.1002/cbdv.200790152
  • Kosa, K. M., Giombi, K. C., Rains, C. B., & Cates, S. C. (2017). Consumer use and understanding of labelling information on edible marijuana products sold for recreational use in the states of Colorado and Washington. International Journal of Drug Policy, 43, 57–66.
  • Krippendorff, K. (2004). Content analysis. An introduction to its methodology. Thousand Oaks, CA: SAGE.
  • Krueger, R. A., & Casey, M. A. (2000). Focus groups. A practical guide for applied research (3rd ed.). Thousand Oaks, CA: SAGE Publications.
  • Laumon, B., Gadegbeku, B., Martin, J. L., & Biecheler, M. B. (2005). Cannabis intoxication and fatal road crashes in France: Population based case-control study. British Medical Journal, 331(7529), 1371.
  • Moir, D., Rickert, W. S., Levasseur, G., Larose, Y., Maertens, R., White, P., & Desjardins, S. (2008). A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chemical Research in Toxicology, 21(2), 494–502. doi:https://doi.org/10.1021/tx700275p
  • Monte, A. A., Zane, R. D., & Heard, K. J. (2015). The implications of marijuana legalization in Colorado. Journal of the American Medical Association, 313(3), 241–242.
  • Novotny, M., Merli, F., Weisler, D., Fencl, M., & Saeed, T. (1982). Fractionation and capillary gas chromatographic–mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates. Journal of Chromatography A, 238(1), 141–150.
  • O'Connell, T. J., & Bou-Matar, C. B. (2007). Long term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal, 4, 16. doi:10.1186/1477-7517-4-16
  • Pacula, R., Jacobson, M., & Maksabedian, E. J. (2016). In the weeds: A baseline view of cannabis use among legalizing states and their neighbours. Addiction, 111(6), 973–980. doi:10.1111/add.13282
  • Pletcher, M. J., Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., … Kertesz, S. (2012). Association between marijuana exposure and pulmonary function over 20 years. Journal of the American Medical Association, 307(2), 173–181. doi:10.1001/jama.2011.1961
  • Schauer, G. L., King, B. A., Bunnell, R. E., Promoff, G., & McAfee, T. A. (2016). Toking, vaping, and eating for health or fun marijuana use patterns in adults, US, 2014. American Journal of Preventive Medicine, 50(1), 1–8. doi:10.1016/j.amepre.2015.05.027
  • Shiplo, S. (2015). Marijuana use in Canada: Patterns of use among medical marijuana users. (Unpublished master's thesis). University of Waterloo, Waterloo, ON, Canada. Retrieved from https://uwspace.uwaterloo.ca/bitstream/handle/10012/9551/Shiplo_Samantha.pdf?sequence=1&isAllowed=y
  • Swift, W., Gates, P., & Dillon, P. (2005). Survey of Australians using cannabis for medical purposes. Harm Reduction Journal, 2, 18.
  • Tashkin, D. P., Baldwin, G. C., Sarafian, T., Dubinett, S., & Roth, M. D. (2002). Respiratory and immunologic consequences of marijuana smoking. Journal of Clinical Pharmacology, 42(11, Suppl), 71S–81S.
  • Tashkin, D. P., Gliederer, F., Rose, J., Change, P., Hui, K. K., Yu, J. L., & Wu, T. C. (1991). Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Pharmacology, Biochemistry, and Behavior, 40(3), 651–656. doi:https://doi.org/10.1016/0091-3057(91)90377-E
  • Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167(3), 221–228.
  • Vandrey, R., Raber, J. C., Raber, M. E., Douglass, B., Miller, C., & Bonn-Miller, M. O. (2015). Cannabinoid dose and label accuracy in edible medical cannabis products. Journal of the American Medical Association, 313(24), 2491–2493. doi:10.1001/jama.2015.6613
  • Wash. Admin. Code § 314-55-105 Packaging and labeling requirements. (2016).
  • Washington State Liquor and Cannabis Board. (2015). Weekly marijuana report. Retrieved from http://lcb.wa.gov/marj/dashboard

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.